In our first episode, dive into the thrilling world where nostalgia meets investment! Forget stocks and bonds — we're talking trading cards. Witness million-dollar deals, legendary collectibles, and the passionate community behind them. From vintage treasures to modern-day chases, discover why trading cards are the hottest alternative asset. #NotFinancialAdvice. Hear from experts, brokers, and even Tom Brady about this explosive market. Beware, it's not just about luck; it's about knowledge, strategy, and a dash of obsession. Get ready to unlock the secrets of the trading card craze, and see if you've got what it takes to play the game. (Hint: You probably haven't, but those cards are niiiiiiice).
Nvidia to make half a trill's worth of tech in U.S.
Nvidia $NVDA ( ▲ 1.35% ) has announced plans to produce AI servers in the United States worth up to $500 billion over the next four years as part of the Trump administration's push for more local manufacturing. The production will include Blackwell $BLKWF ( 0.0% ) AI chips manufactured in Phoenix, Arizona, and supercomputers built somewhere in Texas. Yee-haw.
Nvidia's initiative aligns with similar commitments from other tech giants like Apple $AAPL ( ▼ 0.19% ) , which has also pledged significant U.S. investments recently. The decision to move production to the U.S. is influenced by the Trump administration's tariffs on Chinese imports.
"Large language models and generative AI are the most important computing platform of our generation," said CEO Jensen Huang. "To meet surging demand, Nvidia is working with U.S. partners to build many of these systems here. The coming wave will create hundreds of thousands of jobs and fuel the economic engines of the U.S. and regions worldwide."
Ah, Easter. A time for rebirth, religion, and to eat Peeps…or not?
Let's be honest: Those fluorescent, sugar-coated marshmallow blobs are the most divisive candy known to humankind. America may have its divisions right now, but the culture's real wedge issue is about to be fought to the death in our Easter baskets.
On one side, you have the Peep Purists. They cherish the weirdly satisfying squish, the sugary crust that gets everywhere, and the slightly vacant stare of those little chick (or bunny?) faces. They might even microwave them into horrifyingly puffy monsters.
On the other side, the Peep Haters. They see only edible styrofoam, unnaturally bright dyes, and a texture akin to chewing on a sugary sponge. To them, Peeps are basket filler, destined to become rock-hard archaeological finds discovered months later behind the sofa.
So, where do you stand in the Great Peep Debate of 2025? Are they a delightful seasonal treat or a crime against confectionery? Let us know. Also: Happy Easter, but may your candy choices be judged.
Harvard has been hit with a $2 billion funding freeze by the Trump administration, apparently over the university's reluctance to bow down to a variety of federal demands. Harvard's President Alan Garber wrote: "No government — regardless of which party is in power — should dictate what private universities can teach, whom they can admit and hire, and which areas of study and inquiry they can pursue." Translation: "Back off, Trump. This is our academic turf, and we don't need your syllabus notes."
The Trump administration believes that federal dollars should not fund what they dub as "dangerous racial discrimination or racially motivated violence," and they've begun deporting international students involved in pro-Palestinian protests.
Harvard is now seeking a $750 million loan from Wall Street to fill the funding gap. If there's one thing Harvard knows, it's how to handle money — since it has a $52 billion endowment. We'll see you in court!
Who's right? Harvard? The Trump administration? Let us know in today's poll below!
Trump "investigating" more tariffs on pills, chips
Ladies and gentlemen, welcome to Act III in the ongoing drama (comedy? tragedy? history play?) of Donald Trump's trade policy. The president has decided to channel his inner Sherlock Holmes and launch "investigations" into the importation of pharmaceuticals and semiconductor chips. The reason? National security, because nothing screams "terrorism" like grandma's blood pressure medication and the microchips in your smart toaster.
Seriously, though, we're talking about using Section 232 of the Trade Expansion Act of 1962 here. That's the national emergency statute that's been used to justify the tariffs so far. Trump argues that our reliance on foreign production for these essential items puts us in a precarious position. I realize he didn't investigate any of the other tariffs before announcing them, but recent stock market corrections appear to have persuaded the president to be a bit more cautious before going further this time around. A top Federal Reserve official has called the tariff saga one of the biggest shocks to hit the U.S. economy in decades. Awks.
So, what now? We're entering a 21-day public comment period where everyone from healthcare giants to tech wizards will lobby for leniency. Nvidia, you may have noticed, has been "lobbying" ahead of time by announcing half a trillion dollars more of U.S. production. Meanwhile other tech company CEOs are out there stating the obvious: Tariffs will likely affect consumers, first and foremost.
Cheddar readers have not been pro-tariff, generally, according to our recent polling, but perhaps you'll be excited to hear about more tariffs in the offing this time? Let us know in today's second poll of the day below! #Democracy
No government — regardless of which party is in power — should dictate what private universities can teach, whom they can admit and hire, and which areas of study and inquiry they can pursue.
Wait for it: Leslie Odom Jr. returning to 'Hamilton'
Get ready, "Hamilton" fans — the original Aaron Burr, sir, is making a sensational return! Leslie Odom Jr. is set to reprise his iconic role on Broadway for a limited engagement.
Odom Jr.'s portrayal of the complex, driven Aaron Burr earned him critical acclaim and legions of fans, culminating in a Tony Award for Best Actor in a Musical. His performance was integral to the original cast's legendary run, defining the character for a generation.
News of his return is sending waves of excitement through the theatre community. Seeing the original Burr step back onto the Richard Rodgers Theatre stage promises an unforgettable experience. Details on specific dates are emerging, but one thing is clear: Tickets will be hotter than ever.
